1. Alexander, D.J. (2000). Highly pathogenic avian influenza. InOIE Manual of Standards for Diagnostic Tests and Vaccines4th edn (pp. 212–220). Paris: Office International des Epizooties.
2. Alexander, D., Meulemans, G., Kaleta, E., Capua, I., Marangon, S., Pearson, J. & Lister, S. (2000). Definition of avian influenza: the use of vaccination against avian influenza. InReport of the Scientific Committee on Animal Health and Welfare of the European Commission. Sanco/B3/AH/R17/2000.
3. Development of a DIVA (Differentiating Infected from Vaccinated Animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza
4. Ellis, T.M., Bousfield, R.B., Bissett, L., Dyrting, K.C., Luk, G.S.M., Tsim, S.T., Sturm-Ramirez, K., Webster, R.G., Guan, Y. & Peiris, J.S. (2004a). Investigation of outbreaks of highly pathogenic H5N1 avian influenza in waterfowl and wild birds in Hong Kong in late 2002.Avian Pathology(in press).
5. Ellis T.M. Sims L.D. Wong H.K.H. Bissett L.A. Dyrting K.C. Chow K.W. Wong C.W. Evaluation of vaccination to support control of H5N1 avian influenza in Hong Kong, Wageningen UR Frontis Series: Avian influenza, prevention and control Koch G., Schrijver R. (eds) Kluwer Academic Publishers (in press): Dordrecht 2004b